Patents by Inventor Bradley H. Strauss

Bradley H. Strauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9345509
    Abstract: Devices and methods are disclosed for widening a channel in a treatment site, the channel containing a guide-wire. The channel is widened by advancing an elongated dilation device, which is configured to fit tightly over the guide-wire at the distal tip of the dilation device and to provide a distal dilating surface, over the guide-wire and at least partially through the treatment site. The dilation device comprises a tubular metallic shaft, typically a metal inner tube, for providing sufficient stiffness and column strength for the dilator to be advanced at least partially through the channel, and a flexible sleeve providing a tapered distal tip. The distal end of the dilator defines a leading surface that is shaped to force away portions of a lesion surrounding the guide-wire away from the guide-wire as the distal end is advanced over the guide-wire through the lesion, whereby a channel through the lesion is at least partially dilated.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: May 24, 2016
    Assignees: BAYLIS MEDICAL COMPANY INC.
    Inventors: Gareth Davies, Maria Luk, Thomas C. Waram, Bradley H. Strauss
  • Publication number: 20140107681
    Abstract: Devices and methods are disclosed for widening a channel in a treatment site, the channel containing a guide-wire. The channel is widened by advancing an elongated dilation device, which is configured to fit tightly over the guide-wire at the distal tip of the dilation device and to provide a distal dilating surface, over the guide-wire and at least partially through the treatment site. The dilation device comprises a tubular metallic shaft, typically a metal inner tube, for providing sufficient stiffness and column strength for the dilator to be advanced at least partially through the channel, and a flexible sleeve providing a tapered distal tip. The distal end of the dilator defines a leading surface that is shaped to force away portions of a lesion surrounding the guide-wire away from the guide-wire as the distal end is advanced over the guide-wire through the lesion, whereby a channel through the lesion is at least partially dilated.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicants: Baylis Medical Company Inc.
    Inventors: Gareth Davies, Maria Luk, Thomas C. Waram, Bradley H. Strauss
  • Patent number: 8617192
    Abstract: Flexible sleeve having a leading (distal) edge that can be advanced over a conventional angioplasty guide-wire to facilitate balloon angioplasty catheter and stent catheter crossing complex coronary lesions such as chronic total occlusions or heavily calcified, non-compliant lesions.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: December 31, 2013
    Inventors: Bradley H. Strauss, Thomas C. Waram
  • Patent number: 8512311
    Abstract: Method of preparing a clogged animal vessel, e.g. chronic total occlusion of an artery so as to be capable of crossing by a guidewire of an intraluminal device, e.g., angioplasty balloon. The method includes delivering an angiogenic agent to the occlusion site to promote angiogenesis within the occlusion to increases susceptibility to crossing.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: August 20, 2013
    Inventors: Bradley H. Strauss, Amit Segev
  • Patent number: 8172757
    Abstract: Forward-looking ultrasound transducers are positioned at the tip of a transseptal catheter to facilitate transseptal puncture and interventions within the left atrium, pulmonary veins and mitral valve. Catheter devices and systems are guided by forward-looking ultrasound or optical coherence tomography imaging for penetrating from one location within a mammalian patient's body to another location, and/or performing diagnostic or therapeutic interventions. A penetrator, diagnostic, or interventional device (eg. probe, biopsy apparatus, electrode, needle) is positioned at the catheter tip and is advanceable from the catheter to a target location outside of the lumen in which the catheter is positioned. The imaging probe uses forward-looking ultrasound or optical coherence tomography that allows one to locate both the target and the medical device.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: May 8, 2012
    Assignee: Sunnybrook Health Sciences Centre
    Inventors: Ronen Jaffe, Bradley H. Strauss, Brian K. Courtney
  • Patent number: 8021660
    Abstract: The use of a collagenase containing formulation for degrading collagen within an occlusive atherosclerotic plaque in a chronic fibrotic occlusion, chronically occluded animal tube or cavity. A medical-related apparatus is provided comprising a medical-related device having provided thereto a therapeutic amount of a collagen degrading composition comprising a proteiolytic enzyme containing formulation A method is provided for treating chronically occluded animal tubes and cavities by administering a therapeutic effective amount of a proteolytic enzyme-containing formulation adjacent to an occluding atherosclerotic plaque, waiting for a pre-angioplasty waiting period, followed by crossing the plaque with an angioplasty guide wire.
    Type: Grant
    Filed: September 16, 2008
    Date of Patent: September 20, 2011
    Inventor: Bradley H. Strauss
  • Publication number: 20090088648
    Abstract: Forward-looking ultrasound transducers are positioned at the tip of a transseptal catheter to facilitate transseptal puncture and interventions within the left atrium, pulmonary veins and mitral valve. Catheter devices and systems are guided by forward-looking ultrasound or optical coherence tomography imaging for penetrating from one location within a mammalian patient's body to another location, and/or performing diagnostic or therapeutic interventions. A penetrator, diagnostic, or interventional device (eg. probe, biopsy apparatus, electrode, needle) is positioned at the catheter tip and is advanceable from the catheter to a target location outside of the lumen in which the catheter is positioned. The imaging probe uses forward-looking ultrasound or optical coherence tomography that allows one to locate both the target and the medical device.
    Type: Application
    Filed: June 18, 2008
    Publication date: April 2, 2009
    Inventors: Ronen Jaffe, Bradley H. Strauss, Brian K. Courtney
  • Publication number: 20090074744
    Abstract: The use of a collagenase containing formulation for degrading collagen within an occlusive atherosclerotic plaque in a chronic fibrotic occlusion, chronically occluded animal tube or cavity. A medical-related apparatus is provided comprising a medical-related device having provided thereto a therapeutic amount of a collagen degrading composition comprising a proteiolytic enzyme containing formulation A method is provided for treating chronically occluded animal tubes and cavities by administering a therapeutic effective amount of a proteolytic enzyme-containing formulation adjacent to an occluding atherosclerotic plaque, waiting for a pre-angioplasty waiting period, followed by crossing the plaque with an angioplasty guide wire.
    Type: Application
    Filed: September 16, 2008
    Publication date: March 19, 2009
    Inventor: Bradley H. STRAUSS
  • Publication number: 20090054875
    Abstract: Flexible sleeve having a leading (distal) edge that can be advanced over a conventional angioplasty guide-wire to facilitate balloon angioplasty catheter and stent catheter crossing complex coronary lesions such as chronic total occlusions or heavily calcified, non-compliant lesions.
    Type: Application
    Filed: February 22, 2007
    Publication date: February 26, 2009
    Inventors: Bradley H. Strauss, Thomas C. Waram
  • Patent number: 7425326
    Abstract: The use of a collagenase containing formulation for degrading collagen within an occlusive atherosclerotic plaque in a chronic fibrotic occlusion, chronically occluded animal tube or cavity. A medical-related apparatus is provided comprising a medical-related device having provided thereto a therapeutic amount of a collagen degrading composition comprising a proteiolytic enzyme containing formulation. A method is provided for treating chronically occluded animal tubes and cavities by administering a therapeutic effective amount of a proteolytic enzyme-containing formulation adjacent to an occluding atherosclerotic plaque, waiting for a pre-angioplasty waiting period, followed by crossing the plaque with an angioplasty guide wire.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: September 16, 2008
    Inventor: Bradley H. Strauss